Federal Circuit Affirms that Medical Devices are Only Listable in the Orange Book if They Claim the Active Drug Ingredient
In the AIPLA Spring 2025 newsletter, Nath, Goldberg & Meyer ‘s Joshua Goldberg and Leia Dingott discuss how Court of Appeals for the Federal Circuit (CAFC) affirmed the decision by the U.S. District Court in New Jersey, which ordered the delisting of five U.S. Patents owned by TEVA on the ground “that the Inhaler Patents [...]
